Post-earnings recap
Reported
Fri, Aug 7, 2026
EPS actual
$1.74
EPS est.
—
EPS surprise
—
1-day move
-1.78%
The earnings report indicates that National HealthCare Corporation's EPS was reported at $1.74, but there was no revenue data available. The stock reacted negatively, declining by 1.78%, which may reflect investor uncertainty due to the lack of detailed guidance and commentary from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.74 | N/A | — |
| Revenue | N/A | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.
National HealthCare Corporation (NHC) operates in the health care sector, focusing on health care facilities. With a market cap of $3 billion, the company plays a vital role in providing essential health services, particularly as the demand for health care continues to grow due to an aging population and increasing health awareness.
Last quarter
In Q1-2026, NHC reported an EPS of $1.91, reflecting a positive performance that led to a 10.15% increase in stock price the following day. The company has shown resilience in its operations despite market fluctuations.
EPS beat streak
0Q
EPS beat rate
0%
Avg EPS surprise
+0.00%
Avg 1-day reaction
+2.53%
Overall expectations for NHC are mixed as the market awaits clarity on earnings and revenue figures. Investors are particularly interested in how the company will navigate ongoing challenges in the health care sector.
Bull case
The optimistic view hinges on strong earnings growth driven by increased demand for health care services and effective cost management, potentially leading to a positive surprise in EPS.
Bear case
Conversely, the pessimistic outlook suggests that rising operational costs and regulatory challenges could negatively impact profitability, resulting in disappointing earnings.
The print will turn on these.
Q1
What will the EPS be this quarter, and how does it compare to previous quarters?
EPS is a key measure of profitability, and any significant deviation from past performance could influence investor sentiment.
Q2
How is NHC addressing rising operational costs in the current economic climate?
Understanding the company's strategy for managing costs will be crucial for assessing its ability to maintain profitability.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±9.2%
Why consensus could be wrong
The Street may underestimate NHC's ability to leverage operational efficiencies, which could lead to better-than-expected earnings despite rising costs.
Supporting evidence
NHC's historical performance shows resilience even in challenging quarters, with stock reactions often reflecting underlying strength.
The current options pricing suggests a higher expected volatility, indicating that traders may anticipate a significant move based on earnings.
Key risk
If EPS comes in above $2.00, it could significantly shift the market's perception of NHC's operational strength.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on NHC's ability to manage costs and deliver solid earnings amidst a challenging health care landscape.
Bull confirmed if
An EPS of $2.00 or higher would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS below $1.70 would support the bear case, suggesting significant challenges in profitability.
What the market is pricing for the move.
Implied Move
±3.89%
Historical Avg
±3.1%
The options market is pricing in a move of about 3.89%, indicating that traders expect some volatility around the earnings announcement.
Options are pricing ±3.9% while NHC has averaged ±3.1% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
46.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If NHC beats expectations, history suggests a potential stock increase of around 3% to 5%, confirming strong operational health.
In line / cautious
An in-line report may lead to a muted reaction, as investors await further commentary on future guidance.
Miss
If the company misses expectations, history suggests a potential decline of around 3% to 5%, reflecting investor disappointment.
The lines on the call that would change the story.